Protective Effects of Bacillus coagulans JA845 against D-Galactose/AlCl3-Induced Cognitive Decline, Oxidative Stress and Neuroinflammation
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Recently, the efficacy of probiotics in treatment of neurodegenerative disorders has been reported in animal and clinical studies. Here, we assessed the effects of Bacillus coagulans JA845 in counteracting the symptoms of D-galactose (D-gal)/AlCl3-induced Alzheimer’s disease (AD) in a mice model through behavioral test, histological assessment and biochemical analysis. Ten weeks of pretreatment with B. coagulans JA845 prevented cognitive decline, attenuated hippocampal lesion and protected neuronal integrity, which demonstrated the neuroprotective features of B. coagulans JA845 in vivo. We also found that supplementation of B. coagulans JA845 alleviated amyloid-beta deposits and hyperphosphorylated tau in hippocampus of D-gal/AlCl3-induced AD model mice. Furthermore, B. coagulans JA845 administration attenuated oxidative stress and decreased serum concentration of inflammatory cytokines by regulating the Nrf2/HO-1 and MyD88/TRAF6/NF-κB pathway. Our results demonstrated for the first time that B. coagulans has the potential to help prevent cognitive decline and might be a novel therapeutic approach for the treatment of neurodegenerative diseases.
Abstract
Recently, the efficacy of probiotics in treatment of neurodegenerative disorders has been reported in animal and clinical studies. Here, we assessed the effects of Bacillus coagulans JA845 in counteracting the symptoms of D-galactose (D-gal)/AlCl3-induced Alzheimer’s disease (AD) in a mice model through behavioral test, histological assessment and biochemical analysis. Ten weeks of pretreatment with B. coagulans JA845 prevented cognitive decline, attenuated hippocampal lesion and protected neuronal integrity, which demonstrated the neuroprotective features of B. coagulans JA845 in vivo. We also found that supplementation of B. coagulans JA845 alleviated amyloid-beta deposits and hyperphosphorylated tau in hippocampus of D-gal/AlCl3-induced AD model mice. Furthermore, B. coagulans JA845 administration attenuated oxidative stress and decreased serum concentration of inflammatory cytokines by regulating the Nrf2/HO-1 and MyD88/TRAF6/NF-κB pathway. Our results demonstrated for the first time that B. coagulans has the potential to help prevent cognitive decline and might be a novel therapeutic approach for the treatment of neurodegenerative diseases.
참고문헌 (31)
- Akihiko Takashima, "Amyloid-β, Tau, and Dementia", Journal of Alzheimer's Disease, 17(4), pp.729~736 (2009), IOS Press[DOI]
- Smith MA, "Oxidative stress in Alzheimer’s disease", Biochim. Biophys. Acta, 1502, pp.139~144 (2000)
- Heneka MT, "Neuroinflammation in Alzheimer's disease", Lancet Neurol, 14, pp.388~405 (2015)
- Jiang C, "The gut microbiota and Alzheimer's disease", J. Alzheimers Dis, 58, pp.2018~ (2017)
- George Kerry R, "Benefaction of probiotics for human health : A review", J. Food Drug Anal, 26, pp.927~939 (2018)
- Kobayashi Y, "Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer's disease", Sci. Rep, 7, pp.13510~ (2017)
- Bonfili L, "SLAB51 probiotic formulation activates SIRT1pathway promoting antioxidant and neuroprotective effects in an AD mouse model", Mol. Neurobiol, 55, pp.7987~8000 (2018)
- Cao J, "Probiotic characteristics of Bacillus coagulans and associated implications for human health and diseases", J. Funct. Foods, 64, pp.103643~ (2020)
- Madempudi R, "Randomized clinical trial : the effect of probiotic Bacillus coagulans unique IS2 vs", placebo on the symptoms management of irritable bowel syndrome in adults. Sci. Rep, 9, pp.12210~ (2019)
- La Rosa M, "Prevention of antibiotic-associated diarrhea with Lactobacillus sporogens and fructo-oligosaccharides in children. a multicentric double-blind vs placebo study", Minerva Pediatr, 55, pp.447~452 (2003)
- Fitzpatrick L, "Bacillus coagulans GBI-30, 6086 limits the recurrence of clostridium difficile-induced colitis following vancomycin withdrawal in mice", Gut Pathog, 4, pp.13~ (2012)
- Minamida K, "Effects of dietary fiber with Bacillus coagulans lilac-01 on bowel movement and fecal properties of healthy volunteers with a tendency for constipation", Biosci. Biotechnol. Biochem, 79, pp.300~306 (2015)
- Majeed M, "Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome : a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study", Food Nutr. Res, 62, pp.2018~ (2018)
- Venkataraman R, "Effect of multi-strain probiotic formulation on students facing examination stress : a double-blind, placebo-controlled study", Probiotics Antimicrob. Proteins, 13, pp.12~18 (2021)
- Wang Q, "Lactobacillus plantarum concomitant memantine and treatment attenuates cognitive impairments in APP", PS1 mice, 2020, pp.12, 628~649
- Akbari E, "Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer's disease : a randomized, double-blind and controlled trial", Front. Aging Neurosci, 8, pp.256~ (2016)
- Grady C, "Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease", Brain, 124, pp.739~756 (2001)
- Abulfadl Y, "Protective effects of thymoquinone on D-galactose and aluminum chloride induced neurotoxicity in rats : biochemical, histological and behavioral changes", Neurol. Res, 40, pp.324~333 (2018)
- Serrano-Pozo A, "Neuropathological alterations in Alzheimer disease", Cold Spring Harb. Perspect. Med, 1, pp.a006189~ (2011)
- Varadarajan S, "Review : Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity", J. Struct. Biol, 130, pp.184~208 (2000)
- Haider S, "Naringenin protects AlCl3", D-galactose induced neurotoxicity in rat model of AD via attenuation of acetylcholinesterase levels and inhibition of oxidative stress, 2020, pp.15, e0227631~
- Jensen GS, "Inactivated probiotic Bacillus coagulans GBI-30 induces complex immune activating, anti-inflammatory, and regenerative markers in vitro", J. Inflamm. Res, 10, pp.107~117 (2017)
- Nyangale E, "Bacillus coagulans GBI-30, 6086 modulates faecalibacterium prausnitzii in older men and women", J. Nutr, 145, pp.1446~1452 (2015)
- Walter S, "Role of the Toll-like receptor 4 in neuroinflammation in Alzheimer's disease", Cell Physiol. Biochem, 20, pp.947~956 (2007)
- Lim J, "MyD88 deficiency ameliorates β-amyloidosis in an animal model of Alzheimer's disease", Am. J. Pathol, 179, pp.1095~1103 (2011)
- Lim J-E, "The effects of MyD88 deficiency on exploratory activity, anxiety, motor coordination, and spatial learning in C57BL", 6 and APPswe, Behav. Brain Res, pp.2012, 227[DOI]
- Drouin-Ouellet J, "MyD88 deficiency results in both cognitive and motor impairments in mice", Brain Behav. Immun, 26, pp.880~885 (2012)
- Kanninen K, "Nuclear factor erythroid 2-related factor 2 protects against beta amyloid", Mol. Cell. Neurosci, 39, pp.302~313 (2008)
- Ramsey C, "Expression of Nrf2 in neurodegenerative diseases", J. Neuropathol. Exp. Neuroldlq, 66, pp.75~85 (2007)
- Rojo A, "Nrf2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and tau pathology", Redox biol, 13, pp.444~451 (2017)
- Jazwa A, "Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases", Curr. Drug Targets, 11, pp.1517~1531 (2010)